case 3: atezolizumab/nab-paclitaxel for triple negative breast cancer
Published 4 years ago • 386 plays • Length 5:45Download video MP4
Download video MP3
Similar videos
-
5:54
case 3: treatment after progression in triple-negative breast cancer
-
6:33
case 3: results of the impassion130 trial in metastatic breast cancer
-
5:59
impassion130: atezolizumab and nab-paclitaxel in triple-negative breast cancer
-
4:40
case 3: the use of combination therapy in triple-negative breast cancer
-
2:26
case 3: metastatic triple-negative breast cancer
-
4:27
the impassion130 study in metastatic tnbc
-
1:17
dr. hamilton on fda approval of atezolizumab/nab-paclitaxel in tnbc
-
4:45
atezolizumab plus nab-paclitaxel for advanced triple negative breast cancer
-
7:08
impassion130: results of atezolizumab plus nab-paclitaxel for frontline tnbc
-
1:16
dr. lynce on fda approval of atezolizumab/nab-paclitaxel in tnbc
-
2:24
case 3: managing immune-related adverse effects in tnbc
-
7:36
esmo 2020 expert video report on atezolizumab in upfront treatment of tnbc
-
3:12
atezolizumab with nab-paclitaxel improves survival in breast cancer patients
-
4:15
impassion130: atezolizumab (atezo) nab-paclitaxel (nab-p) vs placebo nab-p in treatment-naiv...
-
4:53
results from the impassion130 trial for triple-negative breast cancer
-
8:50
case 4: chemotherapy or parp inhibitors for brca tnbc
-
3:46
case 4: parp inhibitors for treating brca triple-negative breast cancer
-
1:39:18
expanding the benefits of checkpoint inhibitors and targeted agents in triple-negative breast cancer
-
1:16
the impassion130 trial in metastatic triple-negative breast cancer